Comparing Single-Agent Ibrutinib, Bendamustine Plus Rituximab (BR) and Ibrutinib Plus BR in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): An Indirect Comparison of the RESONATE and HELIOS Trials Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Hillmen, Peter
  • Fraser, Graeme
  • Jones, Jeffrey
  • Rule, Simon
  • O'Brien, Susan
  • Dilhuydy, Marie Sarah
  • Jaeger, Ulrich
  • Grosicki, Sebastian
  • Cymbalista, Florence
  • Sun, Steven
  • Ninomoto, Joi
  • Mahler, Michelle
  • Cheng, Mei
  • Diels, Joris
  • Clow, Fong
  • Salman, Mariya
  • James, Danelle F
  • Howes, Angela
  • Chanan-Khan, Asher

publication date

  • December 3, 2015

published in